Home » Authors » James Etheridge

Articles by James Etheridge

Transgene Licenses Technology To Merck On Nonexclusive Basis

Feb. 5, 2003

By James Etheridge

NicOx, Biolipox Expand Alliance To Areas Of Inflammation, Pain

Feb. 5, 2003

By James Etheridge

Rebif Sales Help Push Serono Over $1.5B In 2002 Revenues

Feb. 5, 2003

By James Etheridge

France Resuming Field Trials Of Genetically Modified Vines

Jan. 29, 2003

By James Etheridge

New French Law Would Allow Embryonic Stem Cell Research

Jan. 29, 2003

By James Etheridge

France Resuming Field Trials Of Genetically Modified Vines

Jan. 29, 2003

By James Etheridge

New French Law Would Allow Embryonic Stem Cell Research

Jan. 29, 2003

By James Etheridge

Adebag Planning Biotechnology Cluster In Southeastern France

Jan. 22, 2003

By James Etheridge

Second Complication Arises In French Gene Therapy Trial

Jan. 22, 2003

By James Etheridge

Cerep Collaborates With Pfizer On BioPrint Database, Software

Jan. 22, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...